Mimura et al. reported that IRE1α inhibitor MKC-3946 prevents XBP1 splicing and inhibits the growth of MM cells under hypoxic condition in vitro and in vivo using a murine xenograft model SCID-hu with a transplanted human bone marrow [15]. This evidence concerns the gene XBP1 and Miyoshi myopathy.